Does the circadian rhythm of melatonin affect ischemia-reperfusion injury after coronary artery bypass grafting?

Heart Surgery Forum

Volumn 12, Issue 2, 2009, Pages

  Sokullu, Onur ^a   Sanioǧlu, Soner ^a   Kurç, Erol ^a   Sargin, Murat ^a   Deniz, Hayati ^a   Tartan, Zeynep ^a   Aka, Serap Aykut ^a   Bilgen, Fuat ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MELATONIN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; HEART EJECTION FRACTION; HEART PROTECTION; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PRIORITY JOURNAL; REPERFUSION INJURY; SURGICAL TECHNIQUE; BLOOD; METABOLIC CLEARANCE RATE; MIDDLE AGED;

CIRCADIAN RHYTHM; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MELATONIN; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY;

EID: 67649649893     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20081150     Document Type: Article

References (13)

1. Brzezinski A. 1997. Melatonin in humans. N Engl J Med 336:186-95.
2. Fourtillan JB, Brisson AM, Fourtillan M, Ingrand I, Decourt JP, Girault J. 2001. Melatonin secretion occurs at a constant rate in both young and older men and women. Am J Physiol Endocrinol Metab 280:E11-22.
3. Gerritsen WB, van Boven WJ, Driessen AH, Haas FJ, Aarts LP. 2001. Off-pump versus on-pump coronary artery bypass grafting: oxidative stress and renal function. Eur J Cardiothorac Surg 20:923-39.
4. Guo X, Kuzumi E, Charman SC, Vuylsteke A. 2002. Perioperative melatonin secretion in patients undergoing coronary artery bypass grafting. Anesth Analg 94:1085-91.
5. Hardeland R, Pandi Perumal SR. 2005. Melatonin, a potent agent in antioxidative defense: actions as a natural food contaminant, gastrointestinal factor, drug and prodrug. Nutr Metab 2:22-31.
6. Kukielka GL, Smith CW, LaRosa GJ, et al. 1995. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95:89-103.
7. Li YH, Teng JK, Tsai WC, Tsai LM, Lin LJ, Chen JH. 1997. Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction. Am J Cardiol 80:1218-21.
8. Nowak JZ, Zawilska JB. 1998. Melatonin and its physiological and therapeutic properties. Pharm World Sci 20:18-27.
9. Reiter RJ, Tan DX. 2003. Melatonin: a novel protective agent against oxidative injury of the ischemic-reperfused heart. Cardiovasc Res 58:10-9.
10. Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki. 2007. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54:1-9.
11. Sakotnik A, Liebmann PM, Stoschitzky K, et al. 1999. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 20:1314-7.
12. Tan DX, Chen LD, Poeggeler B, et al. 1993. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1:57-60.
13. Yin YQ, Luo AL, Guo XY, Li LH, Huang YG. 2007. Postoperative neuropsychological change and its underlying mechanism in patients undergoing coronary artery bypass grafting. Chin Med J 120:1951-57.